← All trials
NCT00400738
Phase 2Interventional
Includes controlled clinical studies conducted to evaluate the effectiveness of the drug for a particular indication or indications in participants with the disease or condition under study and to determine the common short-term side effects and risks.
View on ClinicalTrials.gov ↗Timeline
- Start date
- Mar 1, 2004
- Primary completion
- Dec 1, 2006
- Completion date
- Dec 1, 2006
- First posted
- —
- Last posted
- —
- Enrollment
- 48
- Arms / groups
- 4 / —
- Source
- AACT · pre-existing
Sponsors
- The HIV Netherlands Australia Thailand Research CollaborationLead sponsor
- International Antiviral Therapy Evaluation Center (IATEC)Collaborator
- University of New South WalesCollaborator
- The HIV Netherlands Australia Thailand Research CollaborationOverall official - principal investigator
- The HIV Netherlands Australia Thailand Research CollaborationStudy chair
- Radboud UniversityStudy chair
- National Center in HIV Epidemiology and Clinical ResearchStudy chair
- University of AmsterdamStudy chair
- RocheCollaborator
Drugs studied
Indications studied
CDEK-curated fields only — the ClinicalTrials.gov results mirror (baseline measures, adverse events, participant flow) is a separate, currently-dormant pipeline; see MIGRATION_PLAN.md.